In Silico Exploration of Anti-Inflammatory Activity of Natural Coumarinolignoids

Chemical Biology and Drug Design

Volumn 78, Issue 4, 2011, Pages 567-579

  Meena, Abha ^a   Yadav, Dharmendra K ^a   Srivastava, Ankit ^a   Khan, Feroz ^a   Chanda, Debabrata ^a   Chattopadhyay, Sunil K ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

Anti inflammatory activity; Cleome viscosa; Coumarinolignoids; COX 2 inhibitor; Molecular docking; QSAR

Indexed keywords

ANTIINFLAMMATORY AGENT; CD14 ANTIGEN; CD86 ANTIGEN; COUMARIN DERIVATIVE; COUMARINOLIGNOID DERIVATIVE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; IBUPROFEN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; STAT6 PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ALBINISM; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CLEOME; COMPUTER MODEL; CONTROLLED STUDY; DIFFERENTIATION; DRUG ISOLATION; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVE SITE; EXPERIMENTAL MODEL; IMMUNITY; IN VIVO STUDY; MOLECULAR DOCKING; PLANT SEED; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RISK ASSESSMENT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; CLEOME; COUMARINS; CYCLOOXYGENASE 2 INHIBITORS; HUMANS; MICE; MODELS, MOLECULAR; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SEEDS;

CLEOME VISCOSA; MUS;

EID: 80052635148     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2011.01173.x     Document Type: Article

References (24)

1. Ray A.B., Chattopadhyay S.K., Kumar S. (1985) Structures of cleomiscosins, coumarinolignoids of Cleome viscosa seeds. Tetrahedron;41:209-214.
2. Bawankule D.U., Chattopadhyay S.K, Pal A., Saxena K., Yadav S., Faridi U., Darokar M.P., Gupta A.K., Khanuja S.P.S. (2008) Modulation of inflammatory mediators by coumarinolignoids from Cleome viscosa in female Swiss albino mice. Inflammopharmacol;16:1-6.
3. Bala S., Uniyal G.C., Chattopadhyay S.K., Tripathi V., Sashidhara K.V., Kulshrestha M., Sharma R.P., Jain S.P., Kukreja A.K., Kumar S. (1999) Analysis of taxol and major taxoids in Himalayan yew, Taxus wallichiana. J Chromatogr;858:239-244.
4. Yadav D.K., Meena A., Srivastava A., Chanda D., Khan F., Chattopadhyay S.K. (2010) Development of QSAR model for immunomodulatory activity of natural Coumarinolignoids. Drug Des Devel Ther;4:173-186.
5. Lipinski C.A., Lombardo F., Dominy B., Feeney P. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev;46:3-26.
6. Ertl P., Rohde B., Selzer P. (2000) Calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties. J Med Chem;43:3714-3717.
7. Muegge I. (2000) A knowledge-based scoring function for protein-ligand interactions: probing the reference state. Perspect Drug Discov;20:99-114.
8. Martin C. (1999) A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J Med Chem;42:791-804.
9. Khan F., Meena A., Sharma A. (2010) Docking-based virtual screening of anticancer drugs. Arora R. (ed.), Med Plant Biotech, 15:242-264, CAB International, UK.
10. Meshram J., Ali P., Tiwari V. (2010) Zeolite as an efficient and recyclable activation surface for the synthesis of bis-thiazolidinones: theoretical screening owing to experimental biology. Green Chem Lett Rev;3:195-200.
11. Zhang Y., Li J.X., Zhao J., Wang S.Z., Pan Y., Tanaka K., Kadota S. (2005) Synthesis and activity of oleanolic acid derivatives, a novel class of inhibitors of osteoclast formation. Bioorg Med Chem Lett;15:1629-1632.
12. Sanda P.D., Silva L.D., Zorica D.J., Bojan D.M., Sote M.V., Ivan O.J. (2008) Docking studies and anti-inflammatory activity of β-hydroxy-β-arylpropanoic acids. Molecules;13:603-615.
13. Muzio M., Bosisio D., Polentarutti N., D'amico G., Stoppaciaro A., Mancinelli R., van't Veer C., Penton-Rol G., Ruco L.P., Allavena P., Mantovani A. (2000) Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol;164:5998-6004.
14. Karikó K., Weissman D., Frank A.W. (2004) Inhibition of toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab;24:1288-1304.
15. Selzman C.H. (1998) Ovarian ablation alone promotes aortic intimal hyperplasia and accumulation of fibroblast growth factor. Ann Thorac Surg;98:2049-2054.
16. Williams G., Giroir B.P. (1995) Regulation of cytokine gene expression: tumor necrosis factor, interleukin-1, and the emerging biology of cytokine receptors. New Horiz;3:276-287.
17. Sasaki T., Soh H., Kimura T., Hasegawa T., Okada A., Fukuzawa M. (2005) Recurrent acute pancreatitis caused by malrotation of the intestine and effective treatment with laparoscopic Ladd's procedure. Pediatr Surg Int;21:994-996.
18. Philbinl V.J., Levy O. (2007) Immunostimulatory activity of Toll-like receptor 8 agonists towards human leucocytes: basic mechanisms and translational opportunities. Biochem Soc Trans;35:1485-1497.
19. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., Akira S., Takeda K., Lee J., Takabayashi K., Raz E. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology;126:520-528.
20. Fenton M.J., Golenbock D.T. (1998) LPS-binding proteins and receptors. J Leukoc Biol;64:25-32.
21. Siemasko K., Siemasko K., Eisfelder B.J., Williamson E., Kabak S., Clark M.R. (1998) Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes. J Immunol;160:5203-5208.
22. Sau K., Mambula S.S., Latz E., Henneke P., Golenbock D.T., Levitz S.M. (2003) The antifungal drug amphotericin B promotes inflammatory cytokine release by a toll-like receptor-and CD14-dependent mechanism. J Biol Chem;278:37561-37568.
23. Nirula A., Ho M., Phee H., Roose J., Weiss A. (2006) Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4. J Exp Med;203:1733-1744.
24. Riddell S.R., Elliott M., Lewinsohn D.A., Gilbert M.J., Wilson L., Manley S.A., Lupton S.D., Overell R.W., Reynolds T.C., Corey L., Greenberg P.D. (1996) T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med;2:216-223.